Versive

Versive was a machine learning startup based in Seattle, Washington, US. Founded in 2012 by Stephen Purpura and Chris Metcalfe, the company sells on-premises software, cloud services, and professional service solutions to help businesses automate human expertise.

As of September 2014, Versive has raised $42 million in total investment. The company changed its name from Context Relevant to Versive in 2017. In October 2018, Versive was acquired by eSentire. Provided by Wikipedia
Showing 1 - 7 results of 7 for search 'Chris Metcalfe', query time: 0.02s Refine Results
  1. 1
    Hospital presenting self-harm and risk of fatal and non-fatal repetition: systematic review and meta-analysis.

    Hospital presenting self-harm and risk of fatal and non-fatal repetition: systematic review and meta-analysis. by Robert Carroll, Chris Metcalfe, David Gunnell

    Published 2014-01-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Psychosocial Assessment of Self-Harm Patients and Risk of Repeat Presentation: An Instrumental Variable Analysis Using Time of Hospital Presentation.

    Psychosocial Assessment of Self-Harm Patients and Risk of Repeat Presentation: An Instrumental Variable Analysis Using Time of Hospital Presentation. by Robert Carroll, Chris Metcalfe, Sarah Steeg, Neil M Davies, Jayne Cooper, Nav Kapur, David Gunnell

    Published 2016-01-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    First Dental Steps intervention: feasibility study of a health visitor led infant oral health improvement programme

    First Dental Steps intervention: feasibility study of a health visitor led infant oral health improvement programme by Joanna G. Williams, Patricia Nicole Albers, Sarab El-Yousfi, Zoe Marshman, Reena Patel, Alice Porter, Katrina d’Apice, Katie Breheny, Frank de Vocht, Chris Metcalfe, Robert Witton, Ruth Kipping

    Published 2025-07-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Incorporating Known Genetic Variants Does Not Improve the Accuracy of PSA Testing to Identify High Risk Prostate Cancer on Biopsy.

    Incorporating Known Genetic Variants Does Not Improve the Accuracy of PSA Testing to Identify High Risk Prostate Cancer on Biopsy. by Rebecca Gilbert, Richard M Martin, David M Evans, Kate Tilling, George Davey Smith, John P Kemp, J Athene Lane, Freddie C Hamdy, David E Neal, Jenny L Donovan, Chris Metcalfe

    Published 2015-01-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Strategies adopted by men to deal with uncertainty and anxiety when following an active surveillance/monitoring protocol for localised prostate cancer and implications for care: a longitudinal qualitative study embedded within the ProtecT trial

    Strategies adopted by men to deal with uncertainty and anxiety when following an active surveillance/monitoring protocol for localised prostate cancer and implications for care: a... by Chris Metcalfe, Jenny Donovan, Julia Wade, Vincent J Gnanapragasam, Michael Davis, David Neal, Richard Martin, Athene Lane, Edward Rowe, Freddie Hamdy, James Catto, Emma Turner, David Gillatt, Eleanor Walsh, Derek Rosario, Tim Peters, Roger Kockelbergh, Alan Paul, Peter Holding, Howard Kynaston, Owen Hughes, Prasad Bollina, Alan Doherty, Edgar Paez

    Published 2020-09-01
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Establishment of a core outcome set for burn care research: development and international consensus

    Establishment of a core outcome set for burn care research: development and international consensus by Nukhba Zia, Chris Metcalfe, Jonathan Mathers, Zephanie Tyack, Anna Davies, Sian Falder, Baljit Dheansa, Amber Young, Sara Brookes, Fiona Wood, Jo Dumville, Jamie Kirkham, Tom Potokar, Carmen Tsang, Dale Edgar, Nicole Gibran, Jill Meirte, Teruichi Harada, Rajeev Ahuja, Sarah Gaskell, Sarah Smailes, Marc Jeschke, Murat Ali Cinar, Amr Moghazy, Jane Mary Blazeby

    Published 2022-12-01
    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    Evaluating the population impact of hepatitis C direct acting antiviral treatment as prevention for people who inject drugs (EPIToPe) – a natural experiment (protocol)

    Evaluating the population impact of hepatitis C direct acting antiviral treatment as prevention for people who inject drugs (EPIToPe) – a natural experiment (protocol) by Jeremy Horwood, Andrew Radley, John F Dillon, Peter Vickerman, Rory N Gunson, Mary Ramsay, Chris Metcalfe, William Hollingworth, Hannah Fraser, Helen Harris, Ellen Heinsbroek, Lawrie Elliott, Paul Flowers, Sema Mandal, Matthew Hickman, David Goldberg, Natasha Martin, Emma Hamilton, Daniela De Angelis, Graham Foster, Peter Donnan, Ann Eriksen, Samreen Ijaz, David Liddell, Lewis J Z Beer, Kate Drysdale, Rachel Glass, Lesley Graham, Ross Harris, Vivian Hope, Sarah Karen Inglis, Hamish Innes, Athene Lane, Jade Meadows, Andrew McAuley, Stephanie Migchelsen, Alex Murray, Gareth Myring, Norah E Palmateer, Anne Presanis, Pantelis Samartsidis, Ruth Simmons, Katy Sinka, Gabriele Vojt, Zoe Ward, David Whiteley, Alan Yeung, Sharon J Hutchinson

    Published 2019-09-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: